174 related articles for article (PubMed ID: 16849014)
1. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.
Azarmi S; Huang Y; Chen H; McQuarrie S; Abrams D; Roa W; Finlay WH; Miller GG; Löbenberg R
J Pharm Pharm Sci; 2006; 9(1):124-32. PubMed ID: 16849014
[TBL] [Abstract][Full Text] [Related]
2. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
Dinauer N; Balthasar S; Weber C; Kreuter J; Langer K; von Briesen H
Biomaterials; 2005 Oct; 26(29):5898-906. PubMed ID: 15949555
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process.
Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K
Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795
[TBL] [Abstract][Full Text] [Related]
4. Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nano-particles.
Saxena A; Sachin K; Bohidar HB; Verma AK
Colloids Surf B Biointerfaces; 2005 Sep; 45(1):42-8. PubMed ID: 16112559
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases.
Brzoska M; Langer K; Coester C; Loitsch S; Wagner TO; Mallinckrodt Cv
Biochem Biophys Res Commun; 2004 May; 318(2):562-70. PubMed ID: 15120637
[TBL] [Abstract][Full Text] [Related]
6. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.
Tseng CL; Wang TW; Dong GC; Yueh-Hsiu Wu S; Young TH; Shieh MJ; Lou PJ; Lin FH
Biomaterials; 2007 Sep; 28(27):3996-4005. PubMed ID: 17570484
[TBL] [Abstract][Full Text] [Related]
7. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase: new insights into gelatin nanoparticle cross-linking.
Fuchs S; Kutscher M; Hertel T; Winter G; Pietzsch M; Coester C
J Microencapsul; 2010; 27(8):747-54. PubMed ID: 21034367
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
Balthasar S; Michaelis K; Dinauer N; von Briesen H; Kreuter J; Langer K
Biomaterials; 2005 May; 26(15):2723-32. PubMed ID: 15585276
[TBL] [Abstract][Full Text] [Related]
10. Gelatin nanoparticles as a new and simple gene delivery system.
Zwiorek K; Kloeckner J; Wagner E; Coester C
J Pharm Pharm Sci; 2005 Feb; 7(4):22-8. PubMed ID: 15850545
[TBL] [Abstract][Full Text] [Related]
11. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
Gaihre B; Khil MS; Lee DR; Kim HY
Int J Pharm; 2009 Jan; 365(1-2):180-9. PubMed ID: 18790029
[TBL] [Abstract][Full Text] [Related]
12. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
13. Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides.
Zillies J; Coester C
J Pharm Pharm Sci; 2005 Feb; 7(4):17-21. PubMed ID: 15850544
[TBL] [Abstract][Full Text] [Related]
14. Effects of mass ratio, pH, temperature, and reaction time on fabrication of partially purified pomegranate ellagitannin-gelatin nanoparticles.
Li Z; Gu L
J Agric Food Chem; 2011 Apr; 59(8):4225-31. PubMed ID: 21395213
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human gelatin nanoparticles as a protein drug carrier.
Won YW; Kim YH
J Control Release; 2008 Apr; 127(2):154-61. PubMed ID: 18329122
[TBL] [Abstract][Full Text] [Related]
16. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation.
Kaur A; Jain S; Tiwary AK
Acta Pharm; 2008 Mar; 58(1):61-74. PubMed ID: 18337208
[TBL] [Abstract][Full Text] [Related]
17. Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent.
Yılmaz H; Sanlıer SH
Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):69-77. PubMed ID: 23305120
[TBL] [Abstract][Full Text] [Related]
18. Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles.
Dixit N; Vaibhav K; Pandey RS; Jain UK; Katare OP; Katyal A; Madan J
Biomed Pharmacother; 2015 Feb; 69():1-10. PubMed ID: 25661330
[TBL] [Abstract][Full Text] [Related]
19. Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.
Wartlick H; Spänkuch-Schmitt B; Strebhardt K; Kreuter J; Langer K
J Control Release; 2004 May; 96(3):483-95. PubMed ID: 15120904
[TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
